Project Grant HT94252310505
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$2.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,477,108 to Wake Forest University Health Sciences to conduct research on single-implant versus dual-implant fixation of distal femur extra-articular and complete articular fractures. The project will run from September 30, 2023 through September 29, 2027. Wake Forest University Health Sciences, an academic medical center, will lead this research...
This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
The Department of the Army Medical Command awarded a $2,469,162 Project Grant to Wake Forest University Health Sciences (WFUHS) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2025, supports WFUHS's research to compare the efficacy of allograft versus autograft procedures to improve timely return to duty following nonunion among military personnel. The research aims to transform healthcare for service members and the...
This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...
This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
The University of South Florida was awarded a $2,467,635 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "THE IM ABLE 2 STUDY: LONG TERM OUTCOMES TO ADVANCE CARE FOR WARRIORS AND VETERANS USING ADVANCED ANKLE FOOT ORTHOSES," will fund research to study long-term outcomes and advance care for military members and veterans using advanced ankle-foot orthoses. The project will be conducted...
<p>The Defense Health Agency awarded Wake Forest University Health Sciences a $542,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund high-throughput screening to identify lipid nanoparticles effective for systemic delivery to tissues affected by Duchenne muscular dystrophy. The research is scheduled to be completed by September 29, 2025.</p>
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...